Capital Fund Management (CFM)
HZNP

Capital Fund Management (CFM)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Capital Fund Management (CFM)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-126,942
Closed -$3.35M – 2055
2019
Q1 		$3.35M Sell
126,942
-221,285
-64% -$5.24M 0.03% 626
2018
Q4 		$6.8M Sell
348,227
-86,605
-20% -$1.7M 0.06% 416
2018
Q3 		$8.51M Sell
434,832
-99,083
-19% -$1.88M 0.05% 545
2018
Q2 		$8.84M Buy
533,915
+126,477
+31% +$1.93M 0.05% 521
2018
Q1 		$5.79M Buy
407,438
+320,389
+368% +$4.73M 0.03% 636
2017
Q4 		$1.27M Buy
87,049
+31,493
+57% +$442K 0.01% 1130
2017
Q3 		$704K Sell
55,556
-646,299
-92% -$8.22M 0.01% 1079
2017
Q2 		$8.33M Sell
701,855
-116,160
-14% -$1.44M 0.07% 332
2017
Q1 		$12.1M Buy
818,015
+526,076
+180% +$8.52M 0.1% 250
2016
Q4 		$4.72M Buy
291,939
+160,698
+122% +$2.91M 0.04% 515
2016
Q3 		$2.38M Buy
131,241
+77,214
+143% +$1.51M 0.02% 704
2016
Q2 		$890K Buy
54,027
+33,060
+158% +$535K 0.01% 995
2016
Q1 		$347K Sell
20,967
-87,149
-81% -$1.52M ﹤0.01% 1270
2015
Q4 		$2.34M Buy
108,116
+87,816
+433% +$1.71M 0.02% 624
2015
Q3 		$402K Buy
+20,300
New +$641K ﹤0.01% 1124
2015
Q2 		– Sell
-333,975
Closed -$8.67M – 1787
2015
Q1 		$8.67M Buy
333,975
+316,775
+1,842% +$5.81M 0.12% 221
2014
Q4 		$222K Buy
+17,200
New +$215K ﹤0.01% 1463

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Fund Management (CFM)'s HZNP Position: Q2 2019 in Review

Capital Fund Management (CFM) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2019, closing a stake of 126,942 shares — an estimated $3.35M sold.

Capital Fund Management (CFM) first reported a position in HZNP in Q4 2014 and held it in 17 quarters. The position peaked at $12.1M in Q1 2017. 272 funds tracked by Wall St. Rank hold HZNP as of Q2 2019.

  • Capital Fund Management (CFM) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2019 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 126,942 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2019, an estimated $3.35M.
  • Capital Fund Management (CFM) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2014 and held it in 17 quarters.
  • Capital Fund Management (CFM)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12.1M in Q1 2017.
  • 272 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2019, filed 12 Aug 2019.